Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

United Therapeutic (UTHR)

121.01 +1.95 (+1.64%)

10/20/2017  4:00pm

Open:

119.71

Pre. Close:

119.06

High:

121.46

Low:

118.65

Volume:

402,257

Market Cap:

5.26B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

122.37 - 123.31

123.31 - 124.36

Low:

116.25 - 117.1

117.1 - 118.04

Close:

119.61 - 121.24

121.24 - 123.08

Technical analysis  (as of: 2017-10-20 4:42:26 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 145.87     One year: 170.38

Support:

Support1: 118.49    Support2: 114.54

Resistance:

Resistance1: 124.89    Resistance2: 145.87

Pivot:

121.44

Moving Averages:

MA(5): 120.35     MA(20): 120.75

MA(100): 127.27     MA(250): 133.10

MACD:

MACD(12,26): -0.82     Signal(12,26,9): -1.01

%K %D:

%K(14,3): 41.15     %D(3): 44.41

RSI:

RSI(14): 48.47

52-Week:

High: 169.89  Low: 111.11  Change(%): 8.2

Average Vol(K):

3-Month: 49800  10-Days 15603

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
UTHR has closed above bottom band by 42.4%. Bollinger Bands are 44.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to UTHR's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 19 Oct 2017 09:56:15 GMT
United Therapeutics Corporation To Report Third Quarter 2017 Financial Results ...

Fri, 04 Aug 2017 12:47:19 GMT
United Therapeutics Corp. stock surges 9% on report of possible bids for company

Sun, 08 Oct 2017 17:03:45 GMT
United Therapeutics: This Seems To Be The Time To Sell The Stock In 2017

Sat, 21 Oct 2017 16:07:30 GMT
United Therapeutics Corporation (UTHR) CEO Martine A. Rothblatt Sells 1265 ...

Wed, 18 Oct 2017 18:56:15 GMT
United Therapeutics Corporation Risk Points versus Health Care

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

43.00

Shares Float (M)

42.70

% Held by Insiders

1.69

% Held by Institutions

108.39

Shares Short (K)

8210

Shares Short Prior Month (K)

8410

Stock Financials

EPS

8.620

EPS Est. Current Year

10.600

EPS Est. Next Year

10.820

EPS Est. Next Quarter

3.570

Forward EPS

10.663

Book Value (p.s.)

40.890

PEG Ratio

-0.39

Profit Margin

24.18

Operating Margin

59.73

Return on Assets (ttm)

24.9

Return on Equity (ttm)

22.0

Qtrly Rev. Growth

7.8

Gross Profit (p.s.)

35.221

Sales Per Share

37.907

EBITDA (p.s.)

23.488

Qtrly Earnings Growth

Operating Cash Flow (M)

693.60

Levered Free Cash Flow (M)

931.25

FoxReading.com

Valuation

P/E

14.04

P/E Growth Ratio

0.02

P/BV

2.96

P/S

3.19

P/CF

7.50

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.